Pannex Therapeutics
We are the Pannexin 1 channel company, developing a platform of small molecules to target and block pannexin 1 in different therapeutic areas.
About Pannex Therapeutics
Recent Funding lists Pannex Therapeutics under Health and bio. It went through IndieBio (IndieBio NY 03). It was founded by David Bravo, Gerhard Gross and Thomas Gerlach.
Funding rounds
- X account created
- IndieBio NY 03
IIndieBio · batchSource: indiebio.co - Website created
Founders and team
DB
David Bravo Chief Executive Officer & Co-foundersource: pannextherapeutics.comGG
Gerhard Gross Chief Scientific Officer & Co-foundersource: pannextherapeutics.comTG
Thomas Gerlach Chief Strategic Officer & Co-foundersource: pannextherapeutics.com
Investors
Similar Health and bio companies
HHexagon Bio$62M Series B+ · Oct 2026
BBioStack$9.5M Seed · Oct 2026HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026
WWarp Sciences$215M Series A · Oct 2026
PPAM2L Biotechnologies$29.97M Series A · Oct 2026
Questions and sources
Pannex Therapeutics: questions and answers
- Who invested in Pannex Therapeutics?
- Investors on record for Pannex Therapeutics: IndieBio.
- Who founded Pannex Therapeutics?
- Pannex Therapeutics was founded by David Bravo (Chief Executive Officer & Co-founder), Gerhard Gross (Chief Scientific Officer & Co-founder) and Thomas Gerlach (Chief Strategic Officer & Co-founder).
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/pannex-therapeutics (get a free API key).